Physician profile
Robert Jackson Sherertz
NPI 1891770178
$671.68
in general payments reported to CMS, 2019-2025
8 companies · $21.07 in 2025
The $21.07 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $27.01 · 2021: $24.83 · 2022: $15.51 · 2023: $287 · 2024: $157 · 2025: $21.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $196.36 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $117.58 | 2024 | Nuzyra |
| Merck Sharp & Dohme LLC | $84.69 | 2019-2024 | Dificid |
| Janssen Pharmaceuticals, INC | $73.70 | 2019-2023 | Xarelto |
| Insmed, INC. | $72.35 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $53.85 | 2019-2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $52.08 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.07 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sherertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.